Tilray Brands, Inc. Most Important Performance Measures
The measures each proxy statement lists as most important for linking pay to performance (Item 402(v) tabular list), as tagged, newest proxy first.
- 2023-09-27: Measure Adjusted EBITDA.
- 2023-09-27: Measure Consolidated Net Revenue.
- 2024-09-27: Measure Adjusted EBITDA.
- 2024-09-27: Measure Consolidated Net Revenue.
| Proxy filed | Measure |
|---|---|
| 2023-09-27 | Adjusted EBITDA |
| 2023-09-27 | Consolidated Net Revenue |
| 2024-09-27 | Adjusted EBITDA |
| 2024-09-27 | Consolidated Net Revenue |
| 2025-09-26 | Adjusted EBITDA |
| 2025-09-26 | Consolidated Net Revenue |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |